Intrapancreatic Fat Deposition and Metabolic Signatures Across Adiposity Phenotypes in Chinese Adults: A Computed Tomography Analysis
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Wenlu Zong und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Adiposity, Pancreas. Die Arbeit nennt 32 Literaturangaben. Gefördert von: 2023 Qingdao Technology benefiting Demonstration Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To investigate the associations between intrapancreatic fat deposition (IPFD), quantified by the pancreas–spleen attenuation difference (P–S Difference) on non‐enhanced computed tomography (CT), and metabolic biomarkers in Chinese adults, and to distinguish direct and indirect effects of IPFD via body mass index (BMI) and metabolic dysfunction‐associated steatotic liver disease (MASLD). Materials and Methods This single‐centre, retrospective study analysed 558 Chinese adults (mean age 63.8 ± 13.6 years; 44.4% male). IPFD was quantified as the P–S Difference; lower values indicated greater IPFD. Missing data were handled by multiple imputation. Sequentially adjusted multivariable regression, restricted cubic splines, directed acyclic graph‐informed mediation, and stratified analyses were performed.
Results
In the fully adjusted model, lower P–S Difference was independently associated with higher fasting plasma glucose (FPG; β = −0.0068, 95% CI −0.0136 to 0.0000; p = 0.049), triglycerides (TG; β = −0.0023, [−0.0043 to −0.0002]; p = 0.028), free fatty acids (FFA; β = −0.0012, [−0.0021 to −0.0003]; p = 0.012), and triglyceride glucose (TyG) index (β = −0.0028, [−0.0046 to −0.0010]; p = 0.002), and with lower high‐density lipoprotein cholesterol (HDL‐C; β = 0.0013, [0.0002 to 0.0024]; p = 0.025). Associations with clinical diagnoses (hypertension, metabolic syndrome, type 2 diabetes and coronary heart disease) were non‐significant after adjustment. BMI mediated ≤ 7.1% of associations, whereas MASLD partially mediated TG (22.5%, p = 0.017) and TyG (15.7%, p = 0.019).
Conclusions
IPFD was associated with an early metabolic signature, notably elevated TG, FFA, and TyG, independent of BMI and MASLD. Prospective validation is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Hospital of Qingdao University, Qingdao, China.
- Pancreatic Center, Department of Gastroenterology, Yangzhou Key Laboratory of Pancreatic Disease, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
ORCID-Profile: Wenlu Zong
Förderung
- 2023 Qingdao Technology benefiting Demonstration Project
- National Natural Science Foundation of China
Zitieren
APA
Zong, W., Yu, J., Zhang, Q., Jiang, C., Meng, P., Tian, Z., Lu, G., & Li, X. (2026). Intrapancreatic Fat Deposition and Metabolic Signatures Across Adiposity Phenotypes in Chinese Adults: A Computed Tomography Analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70875
Vancouver
Zong W, Yu J, Zhang Q, Jiang C, Meng P, Tian Z, et al. Intrapancreatic Fat Deposition and Metabolic Signatures Across Adiposity Phenotypes in Chinese Adults: A Computed Tomography Analysis. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70875
BibTeX
@article{Zong2026,
author = {Zong, Wenlu and Yu, Jiaqing and Zhang, Qi and Jiang, Chen and Meng, Pin and Tian, Zibin and Lu, Guotao and Li, Xiaoyu},
title = {Intrapancreatic Fat Deposition and Metabolic Signatures Across Adiposity Phenotypes in Chinese Adults: A Computed Tomography Analysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70875}
}
EUVIMED